NeuroSense Therapeutics Ltd. (NRSN) Operating cash flow 2021–2025
NeuroSense Therapeutics Ltd. (NRSN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.7MFY2025 · since FY2021: -$1.5M → -$7.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.7M | +24.3% |
| FY2024 | -$10.1M | -21.3% |
| FY2023 | -$8.4M | -9.7% |
| FY2022 | -$7.6M | -394.9% |
| FY2021 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NRSN financial trends
NRSN RevenueNRSN Net incomeNRSN Net marginNRSN Gross profitNRSN Gross marginNRSN Operating incomeNRSN Operating marginNRSN Free cash flowNRSN Capital expendituresNRSN Return on equityNRSN Stock buybacksNRSN Dividends paidNRSN Total assetsNRSN Total liabilitiesNRSN Shareholders’ equityNRSN overview →